{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A survey to understand usage pattern of Levetiracetam in patients with epilepsy in India

Survey Questionnaire Form
Doctor’s details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of Epilepsy do you see in a month? *

  2. From your clinical practice, mention % of different types of epilepsy patient that are diagnosed/visit your clinic ? *
    3. Focal onset seizures
    %
    Generalized seizures
    %
    Unknown onset
    %
  3. In your clinical practice, what % of patients progress from focal onset seizures to secondary generalized seizures? *

  4. What are the typical presenting symptoms that lead you to suspect partial onset seizures in a patient? *
    5. A.
    B.
    C.
    D.
    E.
  5. Which diagnostic tests do you routinely use to confirm an epilepsy diagnosis? (Select all that apply) *

  6. Do you routinely assess potential seizures triggers in patients with focal seizures? *

  7. What is the preferred first-line of medication for treating focal onset seizures in adults? *

  8. What is the preferred first-line of medication for treating focal onset seizures in children below 16 years of age? *

  9. How often do you adjust antiepileptic medication doses in patients with focal onset seizure? *

  10. In what % of Patients do you prescribe levetiracetam for the treatment of epilepsy? *

  11. In which type of epilepsy do you primarily use Levetiracetam? (Select all that apply) *

  12. Is levetiracetam your preferred first-line anti-epileptic medication for newly diagnosed epilepsy? *

  13. What factors influence your decision to prescribe levetiracetam over other antiepileptics drugs? *

  14. What is your usual starting dose of levetiracetam for adults with epilepsy? *

  15. How do you typically titrate levetiracetam to achieve optimal seizure control? *

  16. In your practice, do you prefer using levetiracetam as monotherapy or adjunctive therapy? *

  17. How do you assess the treatment response to levetiracetam in patients with epilepsy? *

  18. Do you find the ready-to-use (RTU) injection of levetiracetam convenient for managing acute seizure or status epilepticus? *

  19. What are the primary advantages you see in using the ready-to-use (RTU) injection formulation of levetiracetam over traditional intravenous preparations? *

  20. Do you have specific considerations when prescribing levetiracetam to pediatric or elderly patients? *

  21. How do you manage potential drug interactions when prescribing levetiracetam with other medications? *

  22. What is your approach to managing epilepsy with levetiracetam in pregnant or lactating patients? *

  23. How do you monitor patients on long-term levetiracetam therapy? *

  24. How satisfied are you with the overall efficacy and tolerability of levetiracetam in your patients? *

  25. Based on your clinical experience, what are the advantages of Levetiracetam compared to other antiepileptic medications? *

  26. What insights or recommendations would you offer to fellow neurologists regarding use of levetiracetam in epilepsy management? *

  27. How has your perspective on levetiracetam evolved over the years on new research findings or clinical experience? *

  28. What percentage of your epilepsy patients experience significant improvement in Quality of Life with Levetiracetam? *

  29. In your practice, what is Levetiracetam’s place in therapy in epilepsy? *
    30. Seizures LEV Monotherapy
    (tick mark)     		LEV Add on
    (tick mark)
    Partial Seizures

    Generalized Tonic-clonic seizures

    Myoclonic seizures

    Absence seizures

    Lennox-Gastaut Syndrome

    Febrile seizures

    Refractory seizures

    Status epilepticus

    Nonepileptic seizures

  30. How would you rate patient’s overall experience of Levetiracetam in epilepsy Management? (5 being very satisfied) *